As one of the most commonly used excipients in pharmaceutical formulations, the swelling property of gelatin capsules is a key physical characteristic that influences the drug release rate and bioavailability. Swelling refers to the phenomenon where the capsule shell absorbs water and undergoes volume expansion upon contact with an aqueous medium. This process directly determines the capsule's disintegration time and drug dissolution behavior.
The swelling process of gelatin capsules can be divided into three stages: the initial wetting stage, the rapid swelling stage, and the equilibrium swelling stage. When the capsule comes into contact with an aqueous medium, the hydrophilic groups on the gelatin molecular chains (such as -COOH and -NH2) rapidly form hydrogen bonds with water molecules, wetting the capsule surface. Subsequently, water molecules penetrate the gelatin's three-dimensional network structure through osmosis, causing an increase in the distance between molecular chains and a significant expansion in capsule volume. Studies have shown that at 37°C, the swelling ratio of gelatin capsules can reach 200%-300%, ultimately forming a gel-like structure.
Factors affecting the swelling of gelatin empty capsules mainly include the gelatin source, degree of cross-linking, ambient temperature, and medium pH. Different animal sources (such as porcine skin, bovine hide, or fish bone) result in variations in the amino acid composition and molecular weight distribution of gelatin, which directly impacts its water absorption capacity. Moderate cross-linking can enhance the capsule's mechanical strength, but excessive cross-linking can hinder water penetration and reduce the swelling rate. An increase in temperature accelerates molecular motion and promotes the swelling process, while acidic or alkaline environments may alter the charge state of gelatin molecular chains, affecting their hydration.
In practical applications, the swelling of gelatin capsules has a dual effect on drug release. On one hand, appropriate swelling ensures that the capsule disintegrates rapidly in the gastrointestinal tract, promoting drug dissolution. On the other hand, overly rapid swelling may lead to drug dumping, while insufficient swelling can cause incomplete drug release. Therefore, by adjusting the gelatin type, adding plasticizers (such as glycerin), or incorporating surfactants, the swelling behavior of capsules can be precisely controlled to meet the release requirements of different drugs.
With the advancement of formulation technology, research on the swelling of gelatin capsules has progressed from macroscopic phenomena to molecular mechanisms. The application of modern analytical techniques, such as Differential Scanning Calorimetry (DSC) and Dynamic Mechanical Analysis (DMA), has provided powerful tools for revealing the conformational changes in molecular chains during the swelling process. In the future, through the genetic engineering of modified gelatin or the creation of composites with natural polymers, it is expected that novel capsule systems with intelligent swelling responses will be developed, further advancing the field of drug delivery technology. If there is any demands on empty capsules, welcome to contact KornnacCaps.
